Correlation Between Virax Biolabs and Aditxt
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Aditxt at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Aditxt into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Aditxt Inc, you can compare the effects of market volatilities on Virax Biolabs and Aditxt and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Aditxt. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Aditxt.
Diversification Opportunities for Virax Biolabs and Aditxt
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Virax and Aditxt is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Aditxt Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aditxt Inc and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Aditxt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aditxt Inc has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Aditxt go up and down completely randomly.
Pair Corralation between Virax Biolabs and Aditxt
Given the investment horizon of 90 days Virax Biolabs is expected to generate 6.05 times less return on investment than Aditxt. But when comparing it to its historical volatility, Virax Biolabs Group is 4.79 times less risky than Aditxt. It trades about 0.03 of its potential returns per unit of risk. Aditxt Inc is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 1,679 in Aditxt Inc on September 12, 2024 and sell it today you would lose (1,644) from holding Aditxt Inc or give up 97.92% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Aditxt Inc
Performance |
| Timeline |
| Virax Biolabs Group |
| Aditxt Inc |
Virax Biolabs and Aditxt Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Aditxt
The main advantage of trading using opposite Virax Biolabs and Aditxt positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Aditxt can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aditxt will offset losses from the drop in Aditxt's long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
| Aditxt vs. Neurobo Pharmaceuticals | Aditxt vs. Dermata Therapeutics | Aditxt vs. Unicycive Therapeutics | Aditxt vs. Revelation Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |